Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Dose Escalation Study of Peptide Vaccines With Activity Against Human Cytomegalovirus

NCT00722839 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00722839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00722839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Dose Escalation Study of Peptide Vaccines With Activity Against Human Cytomegalovirus
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2006
Completion date
April 30, 2012
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonneoplastic condition